KRAS and cancer: For instance, KRAS-driven tumors (a common scenario in MOC) have been shown to depend on certain cell-cycle regulators for survival, suggesting that inhibiting such a partner in KRAS-mutant MOCs could selectively eliminate the cancer cells [82].